PUBLISHER: BCC Research | PRODUCT CODE: 2022675
PUBLISHER: BCC Research | PRODUCT CODE: 2022675
2025 Protein Synthesis Research Review
The global market for enzymes in industrial applications was valued at $7.9 billion in 2024 and is expected to reach $10.8 billion by the end of 2029, at a compound annual growth rate (CAGR) of 6.5% from 2024 through 2029.
The global oligonucleotides market was valued at $8.2 billion in 2024. It’s expected to grow from $9.1 billion in 2025 to reach $15.7 billion by the end of 2030, at a compound annual growth rate (CAGR) of 11.5% from 2025 to 2030.
The global market for protein expression was valued at $4.3 billion in 2024. It’s expected to grow from $4.7 billion in 2025 to reach $7.9 billion by the end of 2030, at a compound annual growth rate (CAGR) of 10.9% from 2025 to 2030.
Report Scope
Protein synthesis is vital for all living organisms, enabling cells to produce the proteins they need to survive and function. It is a basic biological process that builds proteins in cells, which is essential for every cellular function. The key components of protein synthesis are deoxyribonucleic acid (DNA), ribonucleic acid (RNA), ribosomes, and amino acids.
The growing demand for protein therapeutics due to the increase in the prevalence of chronic diseases is a major factor driving this market. Advances in cell-free systems and improved expression vectors, which enhance efficiency and productivity, also help to boost the protein synthesis market. The developments toward cell-free systems, high-throughput technologies, and a focus on personalized medicine also act as key factors for the growth of the protein synthesis market. The high production costs and complex techniques also affect this market's growth.
The market includes major companies such as Novartis, Jazz Pharmaceuticals, Amgen Inc., Novonesis, DSM- Firmenich, Thermo Fisher Scientific Inc, Lonza, Merck KGaA, Agilent Technologies, Cytiva, Illumina Inc, Bio Rad Laboratories Inc, Agilent Technologies Inc, Pfizer Inc., Genentech, USA Inc., and Eli Lilly, which mainly focus on protein therapeutics. The companies focusing on protein synthesis research and development include GenScript ProBio, Aldevron, Creative Biogene, and Tierra Biosciences Inc.
Research Reviews from BCC Research provide market professionals with concise market coverage within a specific research category. This 2025 Research Review of protein synthesis provides a sampling of the type of quantitative market information, analysis, and guidance that BCC Research has been developing since its inception in 1971 to help its customers make informed business decisions. This Research Review includes highlights and excerpts from the following reports published by BCC Research in 2025:
- BIO030M Global Markets for Enzymes in Industrial Applications
- BIO220C Oligonucleotides: Global Markets
- BIO165B Protein Expression: Global Markets
- BIO208D Cell and Gene Therapy Tools and Reagents: Global Markets
- BIO061G Biomarkers: Technologies and Global Markets
After you survey the excerpts in this Research Review, we encourage you to follow up on these topics by checking out the full market research reports associated with each topic. BCC Research looks forward to serving your market intelligence needs in future.
Table of Contents
Chapter 1 Foreword
- Research Review Scope
Chapter 2 Global Markets for Enzymes in Industrial Applications(BIO030M)
- Market Outlook
- Scope of Report
- Market Summary
- Market Overview
- Historical Background of Industrial Enzymes
- Enzyme Nomenclature
- Enzyme Classification
- Classification Based on Chemical Reaction Catalysis
- Market Dynamics
- Market Drivers
- Market Restraints
- Market Opportunities
- Emerging Technologies and Developments
- Advances in Enzyme Engineering
- Artificial Enzymes
- Market Analysis by Type
- Carbohydrase
- Protease
- Polymerase and Nuclease
- Phytase
- Lipase
- Others
- Market Analysis by Source
- Microorganisms
- Plants
- Animals
- Market Analysis by Region
- Market Size and Forecast
- North America
- Asia-Pacific
- Europe
- Rest of the World
- Sustainability in the Industrial Enzymes Market
- Concluding Remarks from BCC
Chapter 3 Protein Expression: Global Markets (BIO165B)
- Market Outlook
- Scope of Report
- Market Summary
- Market Growth Factors
- Emerging Technologies
- Segmental Analysis
- Regional Analysis
- Conclusion
- Market Overview
- Protein Expression Workflow
- Choice of Cell Type
- Choice of Plasmid
- Choice of Cell Expression System
- Market Dynamics
- Market Drivers
- Market Restraints
- Market Opportunities
- Emerging Technologies and Developments
- CRISPR/Cas9 Genome Editing
- Synthetic Biology
- AI Integration in Protein Expression
- Market Breakdown
- Market Breakdown by System Type
- Key Takeaways
- Prokaryotic Expression Systems
- Mammalian Cell Expression Systems
- Yeast Expression Systems
- Insect Cell Expression Systems
- Cell-Free Expression Systems
- Algal-based Expression Systems
- Market Breakdown by Product Type
- Key Takeaways
- Reagents
- Expression Vectors
- Competent Cells
- Instruments
- Services
- Market Breakdown by Region
- Key Takeaways
- North America
- Europe
- Asia-Pacific
- Rest of the World
- Sustainability in the Protein Expression Market
- Understanding ESG Data
- ESG Performance Analysis
- Environmental Performance
- Social Performance
- Governance Performance
- Concluding Remarks from BCC
Chapter 4 Oligonucleotides: Global Markets (BIO220C)
- Market Outlook
- Scope of Report
- Market Summary
- Market Dynamics and Growth Factors
- Emerging Technologies
- Segmental Analysis
- Regional Analysis
- Conclusion
- Market Overview
- Types of Oligonucleotides
- Mechanisms of Action of Oligonucleotides
- Market Dynamics
- Market Drivers
- Market Restraints
- Market Opportunities
- Emerging Technologies and Developments
- Key Takeaways
- Enzymatic Oligonucleotide Synthesis
- Advances in RNAi Delivery Systems
- Circulating miRNA Diagnostics for Noninvasive Health Monitoring
- Market Breakdown
- Key Takeaways
- Oligonucleotide Drugs
- Synthesized Oligos
- Equipment and Reagents
- Services
- Market Breakdown by Region
- Key Takeaways
- North America
- Europe
- Asia-Pacific
- Rest of the World
- Sustainability An ESG Perspective
- ESG Risk Ratings
- Conclusion
Chapter 5 Cell and Gene Therapy Tools and Reagents: Global Markets(BIO208D)
- Market Outlook
- Scope of Report
- Market Summary
- Overview
- Current Market Scenario
- Segmental Analysis
- Regional Market Insights
- Emerging Technologies
- Conclusion
- Market Overview
- Cell and Gene Therapy Overview
- Cell Therapy
- Gene Therapy
- Market Dynamics
- Market Drivers
- Increasing Investments in CGT Research
- Market Restraints
- Market Opportunities
- Emerging Technologies and Developments
- Key Takeaways
- Closed and Automated Systems
- Market Breakdown Analysis
- Key Takeaways
- Immunoassays
- Bioreactors
- Leukapheresis
- GMP Antibodies
- Multiplex Immunoassays
- Vectors
- Cell Separation
- Cryopreservation
- Cell Expansion
- Media
- GMP Proteins
- GMP Small Molecules
- CRS Monitoring
- Market Analysis by Region
- Key Takeaways
- North America
- Europe
- Asia-Pacific
- Rest of the World
- Sustainability to ESG Perspective
- Sustainability Trends and Company Initiatives
- Environmental Factors
- Social Factors
- Governance Factors
- Social and Governance Initiatives
- Concluding Remarks
Chapter 6 Biomarkers: Technologies and Global Markets (BIO061G)
- Market Outlook
- Scope of Report
- Market Summary
- Market Overview
- Market Dynamics
- Market Drivers
- Market Restraint
- Market Opportunities
- Emerging Technologies and Development
- Genomics
- Market Breakdown Analysis
- Market Analysis by Product Type
- Consumables
- Instruments
- Services
- Software
- Market Analysis by Technology
- Proteomics
- Genomics
- Imaging
- Bioinformatics
- Metabolomics
- Market for Peptide Synthesis, by Region
- North America
- Europe
- Asia-Pacific
- Rest of the World
- Sustainability in the Biomarker Market
- ESG Risks and Ratings: Understanding the Data
- BCC Research Viewpoint
Chapter 7 Appendix
- Research Methodology
- Analyst's Credentials
List of Tables
- Table 1 : Global Market for Enzymes in Industrial Applications, by Region, Through 2029
- Table 2 : Historical Events Related to Enzymes, 1830s-Present
- Table 3 : Global Market for Enzymes in Industrial Applications, by Type, Through 2029
- Table 4 : Industrial Applications of Carbohydrase Enzymes
- Table 5 : Major Industrial Applications for Cysteine Protease
- Table 6 : Global Market for Enzymes in Industrial Applications, by Source, Through 2029
- Table 7 : Industrial Applications of Microbial Enzymes
- Table 8 : Global Market for Enzymes in Industrial Applications, by Region, Through 2029
- Table 9 : Primary ESG Goals of Industrial Enzyme Companies
- Table 10 : Global Market for Protein Expression, by Region, Through 2030
- Table 11 : Comparison of Protein Expression Systems and Their Respective Advantagesand Disadvantages
- Table 12 : Advantages, Challenges and Most Common Applications of ProteinExpression Systems
- Table 13 : Global Market for Protein Expression, by Type, Through 2030
- Table 14 : Global Market for Protein Expression, by Product, Through 2030
- Table 15 : Characteristics of Commonly Used Expression Hosts
- Table 16 : Select Protein Expression Services
- Table 17 : Global Market for Protein Expression, by Region, Through 2030
- Table 18 : European-based Companies' R&D Expenditures and Comparison of Their Net Sales, 2023
- Table 19 : Key Focus Areas in ESG Metrics
- Table 20 : ESG Rankings for Major Protein Expression Companies, 2025*
- Table 21 : ESG: Environmental Overview
- Table 22 : ESG: Social Overview
- Table 23 : ESG: Governance Overview
- Table 24 : Global Market for Oligonucleotides, by Region, Through 2030
- Table 25 : FDA-Approved ASOs
- Table 26 : RNAi-Approved Drug List
- Table 27 : Global Market for Oligonucleotides, by Product Type, Through 2030
- Table 28 : Global Market for Oligonucleotides, by Region, Through 2030
- Table 29 : Key Focus Areas in ESG Metrics
- Table 30 : ESG Risk Rankings for Oligonucleotide Companies, 2025
- Table 31 : Global Market for Cell and Gene Therapy Tools and Reagents, by Region, Through 2030
- Table 32 : Global Market for Cell and Gene Therapy Tools and Reagents, by Product Type, Through 2030
- Table 33 : Global Market for Cell and Gene Therapy Tools and Reagents, by Region, Through 2030
- Table 34 : ESG: Environmental Overview
- Table 35 : Key Social and Governance Issues in the Global Market for Cell and Gene Therapy Tools and Reagents
- Table 36 : Global Market for Biomarkers, by Region, Through 2029
- Table 37 : Global Market for Biomarkers, Through 2029
- Table 38 : Global Market for Biomarkers, by Product Type, Through 2029
- Table 39 : Global Market for Biomarkers, by Technology, Through 2029
- Table 40 : Global Market for Peptide Synthesis, by Region, Through 2028
- Table 41 : ESG Rankings for Major Biomarker Companies, 2024*
List of Figures
- Figure 1 : Global Market Shares of Enzymes in Industrial Applications, by Region, 2023
- Figure 2 : Enzyme Engineering Methods
- Figure 3 : Global Market Shares of Enzymes in Industrial Applications, by Type, 2023
- Figure 4 : Industrial Applications of Lipase Enzymes
- Figure 5 : Global Market Shares of Enzymes in Industrial Applications, by Source, 2023
- Figure 6 : Advantages of Microbial Enzymes for Industrial Applications
- Figure 7 : Global Market Shares of Enzymes in Industrial Applications, by Region, 2023
- Figure 8 : Global Market for Enzymes in Industrial Applications, by Region, 2021-2029
- Figure 9 : Sustainability Benefits of Industrial Enzymes
- Figure 10 : Global Market Shares of Protein Expression, by Region, 2024
- Figure 11 : Protein Expression Workflow
- Figure 12 : Global Market Shares of Protein Expression, by Type, 2024
- Figure 13 : Global Market Shares of Protein Expression, by Product, 2024
- Figure 14 : Global Market Shares of Protein Expression, by Region, 2024
- Figure 15 : How a Strong ESG Proposition Benefits Businesses
- Figure 16 : Global Market Shares for Oligonucleotides, by Region, 2024
- Figure 17 : Global Market Shares for Oligonucleotides, by Product Type, 2024
- Figure 18 : Global Market Shares for Oligonucleotides, by Region, 2024
- Figure 19 : Global Market Shares for Cell and Gene Therapy Tools and Reagents, by Region, 2024
- Figure 20 : Market Investments for Cell and Gene Therapy, by Year, 2019-2024
- Figure 21 : Market Investments for Cell and Gene Therapy, by Deal Type, H1 2025
- Figure 22 : Global Market Shares for Cell and Gene Therapy Tools and Reagents, by Product Type, 2024
- Figure 23 : Global Market Shares for Cell and Gene Therapy Tools and Reagents, by Region, 2024
- Figure 24 : Global Market Shares for Biomarkers, by Product Type, 2023
- Figure 25 : Global Market Shares for Biomarkers, by Technology, 2023
